Phillip Samayoa

Phillip Samayoa

Directeur Technique/Scientifique/R&D chez GENERATION BIO CO.
39 ans
Health Technology
Finance
Industrial Services

Profil

Phillip Samayoa is the founder of Dyne Therapeutics, Inc. (2017) and Codiak BioSciences, Inc. (2014).
Dr. Samayoa is currently the Chief Scientific Officer at Generation Bio Co. since 2025.
Former jobs include Director at Merck Research Ventures Fund, Principal at Merck & Co., Inc. (2016), Principal at Atlas Venture Advisors, Inc. (2016-2018), Associate at Flagship Pioneering, Inc., Principal at Bayer Technology Services GmbH, Principal at Infinity Pharmaceuticals, Inc., and Principal at Decision Resources, Inc. Education includes an undergraduate degree from the Massachusetts Institute of Technology (2009) and a doctorate from the University of California San Diego (2012).

Postes actifs de Phillip Samayoa

SociétésPosteDébut
GENERATION BIO CO. Directeur Technique/Scientifique/R&D 10/01/2025

Anciens postes connus de Phillip Samayoa

SociétésPosteFin
Private Equity Investor 31/01/2018
DYNE THERAPEUTICS, INC. Fondateur 01/01/2018
MERCK & CO., INC. Corporate Officer/Principal 30/06/2016
CODIAK BIOSCIENCES Fondateur 31/03/2015
Directeur/Membre du Conseil -
Voir l'expérience en détail de Phillip Samayoa

Formation de Phillip Samayoa

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

87

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées12

Health Technology

Finance

Finance

Industrial Services

Health Technology

Finance

Finance

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Phillip Samayoa
🔇